{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T13:24:23Z","timestamp":1775309063973,"version":"3.50.1"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T00:00:00Z","timestamp":1545091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Netherlands through a partnership with Stichting Aids Fonds","award":["12454"],"award-info":[{"award-number":["12454"]}]},{"name":"NWO-WOTRO","award":["W07.10.101"],"award-info":[{"award-number":["W07.10.101"]}]},{"name":"NWO-WOTRO","award":["W07.10.106"],"award-info":[{"award-number":["W07.10.106"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5,30]]},"DOI":"10.1093\/cid\/ciy1070","type":"journal-article","created":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T17:47:50Z","timestamp":1544723270000},"page":"2158-2160","source":"Crossref","is-referenced-by-count":3,"title":["Does Tenofovir-containing First-line Antiretroviral Therapy Mitigate the Impact of Pretreatment Non-nucleoside Reverse Transcriptase Inhibitor Drug Resistance?"],"prefix":"10.1093","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0155-7391","authenticated-orcid":false,"given":"Seth C","family":"Inzaule","sequence":"first","affiliation":[{"name":"Amsterdam Institute for Global Health and Development, Department of Global Health, Amsterdam University Medical Center, University of Amsterdam"},{"name":"Joep Lange Institute, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias F","family":"Rinke de Wit","sequence":"additional","affiliation":[{"name":"Amsterdam Institute for Global Health and Development, Department of Global Health, Amsterdam University Medical Center, University of Amsterdam"},{"name":"Joep Lange Institute, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raph L","family":"Hamers","sequence":"additional","affiliation":[{"name":"Amsterdam Institute for Global Health and Development, Department of Global Health, Amsterdam University Medical Center, University of Amsterdam"},{"name":"Eijkman-Oxford Clinical Research Unit, Eijkman Institute for Molecular Biology"},{"name":"Faculty of Medicine, Universitas Indonesia, Jakarta"},{"name":"Center for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Pan-African Studies to Evaluate Resistance","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T F R","family":"dW","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,12,18]]},"reference":[{"key":"2019053001010675700_CIT0001","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciy881","article-title":"Impact of next generation sequencing defined HIV pre-treatment drug resistance on virological outcomes in the ANRS 12249 treatment as prevention trial","author":"Derache","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2019053001010675700_CIT0002","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/cid\/civ102","article-title":"Pretreatment HIV drug resistance and HIV-1 subtype C are independently associated with virologic failure: results from the multinational PEARLS (ACTG A5175) clinical trial","volume":"60","author":"Kantor","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2019053001010675700_CIT0003","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1016\/S2352-3018(16)30119-9","article-title":"Pretreatment HIV-drug resistance in Mexico and its impact on the effectiveness of first-line antiretroviral therapy: a nationally representative 2015 WHO survey","volume":"3","author":"\u00c1vila-R\u00edos","year":"2016","journal-title":"Lancet HIV"},{"key":"2019053001010675700_CIT0004","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/cid\/civ656","article-title":"Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa","volume":"61","author":"Boender","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2019053001010675700_CIT0005","doi-asserted-by":"crossref","unstructured":"Chung MH , BeckIA, DrossS, et al Oligonucleotide ligation assay detects HIV drug resistance associated with virologic failure among antiretroviral-naive adults in Kenya. J Acquir Immune Defic Syndr2014; 67:246\u201353.","DOI":"10.1097\/QAI.0000000000000312"},{"key":"2019053001010675700_CIT0006","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/jac\/dku426","article-title":"Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing","volume":"70","author":"Cozzi-Lepri","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2019053001010675700_CIT0007","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1473-3099(11)70255-9","article-title":"Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study","volume":"12","author":"Hamers","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"2019053001010675700_CIT0008","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1093\/jac\/dkx188","article-title":"Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children","volume":"72","author":"Kityo","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2019053001010675700_CIT0009","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1473-3099(11)70032-9","article-title":"Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study","volume":"11","author":"Wittkop","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"2019053001010675700_CIT0010","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciy895","article-title":"The clinical implications of pretreatment drug resistance--a moving target","author":"Shafer","year":"2018","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/68\/12\/2158\/28739384\/ciy1070.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T12:35:29Z","timestamp":1775306129000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/68\/12\/2158\/5251920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,18]]},"references-count":10,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12,18]]},"published-print":{"date-parts":[[2019,5,30]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy1070","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6,15]]},"published":{"date-parts":[[2018,12,18]]}}}